Brief: Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
15/04/2025 21:35
Cardiff Oncology Inc CRDF.O: CARDIFF ONCOLOGY REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX2WZb7s Further company coverage: CRDF.O
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering